ENTITY
HBM Holdings Limited

HBM Holdings Limited (2142 HK)

68
Analysis
Health Care • China
Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases
more
•09 Dec 2020 17:38

HBM (和铂医药) IPO Trading: The Retail Retreat and the Vaccine News

HBM attracted a strong lineup of cornerstone investors but the sentiment is not as strong as previous hot deals. The company announced news in...

Logo
537 Views
Share
bullish•JD Health
•06 Dec 2020 11:36

ECM Weekly (6 December 2020) - Blue Moon Group, Pop Mart, HBM, Burger King India, and More

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•02 Dec 2020 09:36

Harbour Biomed IPO: Positive Thoughts in Brief

This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.

Share
•01 Dec 2020 09:34

Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"

This article analyzed Harbour's core products, team, technology platforms, thoughts on valuation and the "hidden" value that is often easy to be...

Logo
509 Views
Share
•30 Nov 2020 16:57

HBM Holdings (Harbour Biomed) IPO: Valuation Insights

Harbour has launched an HK IPO to raise net proceeds of $205 million at the mid-point of the price range. Overall, strong cornerstones and our...

Logo
947 Views
Share
x